Clinical Trial Update: Oral Iron Supplementation for Patients With Chronic Kidney Disease [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating an oral iron supplement in patients with chronic kidney disease; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia of Chronic Kidney Disease
• Chronic Kidney Disease
• Dysbiosis
• Iron Deficiency Anemia

Drugs mentioned

• Ferrous sulfate (ferrous sulfate)

Snippet

Sponsor: Universidade Federal Fluminense | Conditions: Chronic Renal Disease, Iron-Deficiency Anemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING